within Pharmacolibrary.Drugs.ATC.C;

model C04AX07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.0008,
    adminDuration  = 600,
    adminMass      = 30 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.12,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0006666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C04AX07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Vincamine is a vasodilator alkaloid derived from the Vinca minor plant. It has been mainly used to improve cerebral metabolism and blood flow in elderly patients with cognitive impairment, dementia, or cerebrovascular disorders. Its use today is limited, and it is not widely approved in major markets like the US or Western Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult healthy subjects after oral administration, as there are no well-referenced studies with original PK data available in the public domain.</p><h4>References</h4><ol><li><p>Maincent, P, et al., &amp; Devissaguet, JP (1986). Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles. <i>Journal of pharmaceutical sciences</i> 75(10) 955–958. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600751009&quot;>10.1002/jps.2600751009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3795026/&quot;>https://pubmed.ncbi.nlm.nih.gov/3795026</a></p></li><li><p>Hasa, D, et al., &amp; Voinovich, D (2013). Rationale of using Vinca minor Linne dry extract phytocomplex as a vincamine&#x27;s oral bioavailability enhancer. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 84(1) 138–144. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2012.11.025&quot;>10.1016/j.ejpb.2012.11.025</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23238273/&quot;>https://pubmed.ncbi.nlm.nih.gov/23238273</a></p></li><li><p>Laufen, H, et al., &amp; Bartsch, G (1977). [On the pharmacokinetics of vincamine after i.v. and oral application to the dog (author&#x27;s transl)]. <i>Arzneimittel-Forschung</i> 27(6a) 1255–1264. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20113/&quot;>https://pubmed.ncbi.nlm.nih.gov/20113</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C04AX07;
